(Q80050474)
Statements
Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? (English)
Tobias Welte
Hartmut Derendorf
Olaf Burkhardt
Christine Lehmann
Rajanikanth Madabushi